Phase 2 Kaposi Sarcoma Clinical Trials
8 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–8 of 8 trials
Recruiting
Phase 1Phase 2
Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma
Kaposi Sarcoma
National Cancer Institute (NCI)111 enrolled1 locationNCT04941274
Recruiting
Phase 1Phase 2
PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma
Kaposi Sarcoma
National Cancer Institute (NCI)80 enrolled1 locationNCT04303117
Recruiting
Phase 2
Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)
KSHV Inflammatory Cytokine Syndrome (KICS)Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease
National Cancer Institute (NCI)75 enrolled1 locationNCT06052618
Recruiting
Phase 2
Agnostic Therapy in Rare Solid Tumors
Cancer of Unknown PrimarySoft Tissue SarcomaCholangiocarcinoma+38 more
Instituto do Cancer do Estado de São Paulo28 enrolled8 locationsNCT06638931
Recruiting
Phase 2
Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)
Kaposi Sarcoma
National Cancer Institute (NCI)55 enrolled1 locationNCT07308886
Recruiting
Phase 2
Propranolol for the Treatment of Kaposi Sarcoma in Adults
Kaposi Sarcoma
Washington University School of Medicine25 enrolled1 locationNCT06445166
Recruiting
Phase 2
Trial of Ixazomib for Kaposi Sarcoma
Kaposi SarcomaSkin
AIDS Malignancy Consortium41 enrolled11 locationsNCT04305691
Recruiting
Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Kaposi Sarcoma
Vasgene Therapeutics, Inc65 enrolled3 locationsNCT03993106